Skip to content
Bright Platform

The Zimbabwean Government Declines ‘Lopsided’ US Healthcare Assistance Deal Over Data Fears

Health aid illustration
The offered American funding would have supported programmes for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has rejected a substantial US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years due to the United States' insistence on confidential data.

This move was revealed after a internal memorandum dated December was disclosed, indicating that President Emmerson Mnangagwa deemed the arrangement was "unbalanced".

A government spokesperson later explained that the US was demanding access to genetic material for research and commercial purposes while refused to share the resulting advantages from future medical innovations.

"We are forced to start the challenging and unfortunate process of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had furnished more than $1.9bn in health funding to Zimbabwe during the past two decades.

A medical body in Zimbabwe has called for more talks to reach a agreement suitable to all parties so the country's critical HIV treatment initiative can continue.

Wider Context

This rejection comes after a similar situation in Kenya, where a high court blocked a similar deal with the US following legal challenges were raised about the security of citizens' medical information.

After returning to office recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).

USAID had administered assistance for the US government, but Trump stated its spending was "wasteful" and his administration was seeking direct bilateral deals to boost transparency and accountability.

As per statements, Sixteen nations in Africa have so far signed these new health pacts, constituting over $18.3bn in committed funds.

Details of the Declined Agreement

The money for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this collaboration could have provided extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy via American-funded initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".

"Our nation was requested to share its genetic material and health information over an extended period, with no corresponding promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that could result from that provided information," he stated.

"Put simply, our nation would supply the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our people if a new health crisis arise."

Sovereignty and Global Health

He also pointed out that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were undermining systems previously set up via the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential global health emergencies.

"This mechanism is intended to guarantee that when a nation provides its data, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to create them."

These objections regarding the US deal "should not be misconstrued as anti-American sentiment," he added.

"We are open to continued dialogue with our American counterparts on how subsequent collaboration might be arranged in a way that respects the sovereignty and dignity of each country."

Health Experts Response

A leading public health body stated it understood the government's concerns, but urged that negotiations must proceed since much of the nation's HIV programmes relied on international support.

"In cases where technical issues exist, such as those relating to data governance or agreement terms, these can frequently be addressed via technical clarification and negotiated safeguards," it said.

This impasse emphasises the ongoing challenges between receiving much-needed foreign assistance and safeguarding local interests in an ever more interconnected world.

About the author

Matthew Wolfe

A tech enthusiast and digital strategist with over a decade of experience in software development and emerging technologies.

Bright Platform

Type to search articles.